Report results from the Phase 1 trial of FTX-6058 in healthy adult volunteers
Delivered after the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 4 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- August 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“On track to report results from the Phase 1 trial in healthy adult volunteers with FTX-6058 in development for sickle cell disease (SCD) in mid-2021”
What we found
Evidence strength A What the grades mean
The company reported positive interim Phase 1 results in healthy adult volunteers in August 2021, after the mid-2021 (June 30) deadline.
-
A Fulcrum Therapeutics, Inc. 8-K filed 2021-08-10
“Reported positive interim results from ongoing Phase 1 trial in healthy adult volunteers with FTX-6058 for sickle cell disease” ✓ confirmed on the page
-
A Fulcrum Therapeutics, Inc. 8-K filed 2021-11-04
“In August 2021, reported positive interim results from the ongoing Phase 1 trial in healthy adult volunteers treated with FTX-6058.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Phase 1 results for FTX-6058 in healthy adult volunteers
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- Medium
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Fulcrum Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-FULC-025135 · Corrections policy